tiprankstipranks
Xvivo Perfusion AB (GB:0RKL)
LSE:0RKL
UK Market

Xvivo Perfusion AB (0RKL) Share Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

0RKL Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Xvivo
Perfusion AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0RKL Stock 12 Month Forecast

There Are No Analyst Ratings for GB:0RKL In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

0RKL Financial Forecast

0RKL Earnings Forecast

Next quarter’s earnings estimate for 0RKL is kr0.80 with a range of kr0.64 to kr1.15. The previous quarter’s EPS was kr0.65. 0RKL beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0RKL has Outperformed its overall industry.
Next quarter’s earnings estimate for 0RKL is kr0.80 with a range of kr0.64 to kr1.15. The previous quarter’s EPS was kr0.65. 0RKL beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0RKL has Outperformed its overall industry.

0RKL Sales Forecast

Next quarter’s sales forecast for 0RKL is kr237.57M with a range of kr229.00M to kr246.80M. The previous quarter’s sales results were kr238.99M. 0RKL beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0RKL has Outperformed its overall industry.
Next quarter’s sales forecast for 0RKL is kr237.57M with a range of kr229.00M to kr246.80M. The previous quarter’s sales results were kr238.99M. 0RKL beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0RKL has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Danske Bank Analyst forecast on GB:0RKL
Simon Larsson
Danske Bank
Not Ranked
Danske Bank
kr225
Buy
-10.29%
Downside
Upgraded
10/24/25
Xvivo Perfusion upgraded to Buy from Hold at Danske BankXvivo Perfusion upgraded to Buy from Hold at Danske Bank
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Danske Bank Analyst forecast on GB:0RKL
Simon Larsson
Danske Bank
Not Ranked
Danske Bank
kr225
Buy
-10.29%
Downside
Upgraded
10/24/25
Xvivo Perfusion upgraded to Buy from Hold at Danske BankXvivo Perfusion upgraded to Buy from Hold at Danske Bank
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Xvivo Perfusion AB

3 Months
OpenAI Medical - DevicesTipRanks - OpenAI
Success Rate
1/3 ratings generated profit
33%
Average Return
-3.30%
Copying OpenAI Medical - Devices's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -3.30% per trade.
1 Year
OpenAI Medical - DevicesTipRanks - OpenAI
Success Rate
1/3 ratings generated profit
33%
Average Return
-3.30%
Copying OpenAI Medical - Devices's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -3.30% per trade.
2 Years
OpenAI Medical - DevicesTipRanks - OpenAI
Success Rate
1/3 ratings generated profit
33%
Average Return
-3.30%
Copying OpenAI Medical - Devices's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -3.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0RKL Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, 0RKL has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0RKL average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

0RKL Stock Forecast FAQ

What is GB:0RKL’s average 12-month price target, according to analysts?
Currently, no data Available
What is GB:0RKL’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0RKL, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Xvivo Perfusion AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Xvivo Perfusion AB’s share price target?
      Currently, no data Available
      What do analysts say about Xvivo Perfusion AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Xvivo Perfusion AB?
      To buy shares of GB:0RKL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.